...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Toxicity
Reply New Message
Back To Forum List View
Toxicity
5
jonzobot
Nov 02, 2022 03:10PM
Icon president Re: Toxicity
4
RVXoldtimer
Nov 02, 2022 03:46PM
Re: Toxicity
3
KOO-KOO2
Nov 02, 2022 03:51PM
Re: Toxicity
2
jonzobot
Nov 02, 2022 03:53PM
Icon president Re: Toxicity
3
RVXoldtimer
Nov 02, 2022 04:19PM
Re: Toxicity
1
KOO-KOO2
Nov 02, 2022 04:59PM
Re: Toxicity
3
tada
Nov 02, 2022 09:26PM
Re: Toxicity
6
jonzobot
Nov 03, 2022 03:28PM
Re: Toxicity
4
tada
Nov 03, 2022 04:08PM
Re: Toxicity
2
KOO-KOO2
Nov 03, 2022 04:50PM
Re: Toxicity
4
jonzobot
Mar 22, 2023 03:44PM
Re: Toxicity
5
tada
Mar 24, 2023 02:30PM

Tada,

Wondering if any of BP involved in these Zenith Epigenetics clinical trials will take a leap to lock in this tech before there compeitors do i am sure those BP get a sneak peak at the data and know exactly what the ORR is in a few trials? 

 

 

5 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply